334 related articles for article (PubMed ID: 18024079)
1. Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
Xin J; Wainwright DA; Serpe CJ; Sanders VM; Jones KJ
Brain Behav Immun; 2008 May; 22(4):528-37. PubMed ID: 18024079
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
Deboy CA; Xin J; Byram SC; Serpe CJ; Sanders VM; Jones KJ
Exp Neurol; 2006 Sep; 201(1):212-24. PubMed ID: 16806176
[TBL] [Abstract][Full Text] [Related]
3. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
4. Effects of facial nerve axotomy on Th2- and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice.
Wainwright DA; Xin J; Mesnard NA; Politis CM; Sanders VM; Jones KJ
J Neuroimmunol; 2009 Nov; 216(1-2):66-75. PubMed ID: 19818514
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection.
Serpe CJ; Coers S; Sanders VM; Jones KJ
Brain Behav Immun; 2003 Oct; 17(5):393-402. PubMed ID: 12946661
[TBL] [Abstract][Full Text] [Related]
6. CD4(+) T cell-mediated facial motoneuron survival after injury: Distribution pattern of cell death and rescue throughout the extent of the facial motor nucleus.
Canh MY; Serpe CJ; Sanders V; Jones KJ
J Neuroimmunol; 2006 Dec; 181(1-2):93-9. PubMed ID: 17045343
[TBL] [Abstract][Full Text] [Related]
7. Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice.
Beahrs T; Tanzer L; Sanders VM; Jones KJ
Exp Neurol; 2010 Jan; 221(1):225-30. PubMed ID: 19913014
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells do not mediate facial motoneuron survival after facial nerve transection.
Byram SC; Serpe CJ; Pruett SB; Sanders VM; Jones KJ
Brain Behav Immun; 2003 Dec; 17(6):417-25. PubMed ID: 14583233
[TBL] [Abstract][Full Text] [Related]
9. Immune cell-mediated neuroprotection is independent of estrogen action through estrogen receptor-alpha.
Xin J; Fargo KN; Tanzer L; Sanders VM; Jones KJ
Metab Brain Dis; 2012 Mar; 27(1):23-8. PubMed ID: 21975535
[TBL] [Abstract][Full Text] [Related]
10. Impact of peripheral immune status on central molecular responses to facial nerve axotomy.
Setter DO; Runge EM; Schartz ND; Kennedy FM; Brown BL; McMillan KP; Miller WM; Shah KM; Haulcomb MM; Sanders VM; Jones KJ
Brain Behav Immun; 2018 Feb; 68():98-110. PubMed ID: 29030217
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Differentiation of Effector CD4
Read KA; Powell MD; Sreekumar BK; Oestreich KJ
Methods Mol Biol; 2019; 1960():75-84. PubMed ID: 30798522
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.
Runge EM; Iyer AK; Setter DO; Kennedy FM; Sanders VM; Jones KJ
J Neuroinflammation; 2020 Apr; 17(1):121. PubMed ID: 32303238
[TBL] [Abstract][Full Text] [Related]
13. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
Soler D; Chapman TR; Poisson LR; Wang L; Cote-Sierra J; Ryan M; McDonald A; Badola S; Fedyk E; Coyle AJ; Hodge MR; Kolbeck R
J Immunol; 2006 Nov; 177(10):6940-51. PubMed ID: 17082609
[TBL] [Abstract][Full Text] [Related]
14. Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry.
Kunicki MA; Amaya Hernandez LC; Davis KL; Bacchetta R; Roncarolo MG
J Immunol; 2018 Jan; 200(1):336-346. PubMed ID: 29180490
[TBL] [Abstract][Full Text] [Related]
15. IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection.
Xin J; Wainwright DA; Mesnard NA; Serpe CJ; Sanders VM; Jones KJ
Brain Behav Immun; 2011 Jul; 25(5):820-9. PubMed ID: 20723599
[TBL] [Abstract][Full Text] [Related]
16. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
[TBL] [Abstract][Full Text] [Related]
17. T helper cells plasticity in inflammation.
Cosmi L; Maggi L; Santarlasci V; Liotta F; Annunziato F
Cytometry A; 2014 Jan; 85(1):36-42. PubMed ID: 24009159
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice.
Serpe CJ; Byram SC; Sanders VM; Jones KJ
Brain Behav Immun; 2005 Mar; 19(2):173-80. PubMed ID: 15664790
[TBL] [Abstract][Full Text] [Related]
19. SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.
Mesnard-Hoaglin NA; Xin J; Haulcomb MM; Batka RJ; Sanders VM; Jones KJ
Brain Behav Immun; 2014 Aug; 40():55-60. PubMed ID: 24911596
[TBL] [Abstract][Full Text] [Related]
20. CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells.
Yang L; Kobie JJ; Mosmann TR
J Immunol; 2005 Nov; 175(10):6458-64. PubMed ID: 16272299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
